## SPECT/CT as you have never seen it before
NM/CT 870 CZT is the third-generation of our general purpose digital SPECT/CT system powered by CZT technology. An important capability of NM/CT 870 CZT is the ability to image low energy and medium energy isotopes with energies up to 250 keV. Accessibility to the Medium Energy High Resolution & Sensitivity (MEHRS) collimator, via collimator exchange, will expand your SPECT/CT offering to include Theranostics applications.
## Inform your decisions with measurable results
NM/CT 870 CZT combines its improved small lesion detectability¹ and exceptional image quality with advanced quantitative applications provided through Xeleris™, our Nuclear Medicine, NM/CT and PET/CT processing, analysis, and review system.
## FEATURES
A SPECT/CT system for true discovery
The latest generation offers the SmartConsole, CT features, and the capability of imaging the higher energy peaks of medium energy isotopes. Help bring your theories to life with a system designed to leverage all that CZT can do for a wide variety of procedures.
## DESIGN
Designed for patient comfort and increased versatility
Using registered collimation, NM/CT 870 CZT contains detected events entirely within a single pixel aligned to one collimator hole, even at the outermost edges of the FOV. This reduction in dead space enables a system design can get closer to anatomies and increase patient comfort.
A patient-centric detector design with 67 percent reduction in brain reach makes certain exams more tolerable. Normally, cardiac SPECT scans require patients to extend and hold their arms above their head for a long duration. With NM/CT 870 CZT, scan time may be reduced by up to 75%² and the near frameless detector design can enable patients to hold their arms at a more comfortable angle.
## PRODUCTIVITY
Switch to an all-digital workflow
SmartConsole is a productivity hub for hybrid imaging. Simplify the workflow for complex hybrid and quantitative protocols and allow technologists to review results directly at the scanner console. It allows physicians to review scans remotely from mobile devices. They can modify processing settings and initiate study processing anytime, anywhere across a LAN or a WAN.
SmartConsole enables a noticeable improvement in productivity. Now, a physician can provide their input remotely and digitally. For example, physicians can review a whole-body bone scan directly on their tablet or other mobile device and define the scan range limits they need from wherever they are. The time saved with this switch to a digital workflow helps make it possible to complete exams in predictable time slots.
## BUILT FOR QUANTITATION
Quantitative SPECT/CT for every patient, every day
NM/CT 870 CZT is a SPECT/CT built for consistent, reproducible quantitation. Improvements to detector performance enable exceptional spatial and energy resolution. It also leverages CT-based attenuation and scatter correction along with Evolution3 image reconstruction. In addition, ever-increasing computational power enables precise camera calibration for less variation between exams.
Once your quantitative studies are acquired, SmartConsole - together with Xeleris - makes it easier to access them. Your quantitative SPECT/CT studies are automatically transferred directly to the PACS or other pre-defined DICOM destinations. An additional dataset in PET DICOM format allows you to review and evaluate images on the same devices you use to view your PET/CT studies, as adjacent information to the original SPECT/CT images.
## PRODUCTIVITY
One home for all your molecular images
SmartConsole makes advanced procedures more accessible by transferring exams directly to the PACS or other pre-defined DICOM destinations with no operator intervention, even if SPECT/CT fusion is not supported, by exporting the studies in DICOM PET format. You can generate and send an additional dataset in PET DICOM format to enable quantitative SPECT results and SPECT SUV (Standard Uptake Value) on any PET DICOM compliant workstation or PACS. Referring physicians can review and evaluate your SPECT/CT exams with the same quality of information they have come to expect from your PET/CT, as adjunct information to the original SPECT/CT images.
## See everything clearly now
As molecular imaging continues to move toward the development of disease-specific diagnoses and increasingly personalized care, resolution is important. Early disease detection is only possible with a high system resolution that enables visualization of finer anatomic detail.
The resolution to discover something new
With direct conversion detection, NM/CT 870 CZT has substantially improved system resolution⁴ by eliminating the signal loss and noise that comes with analog detection technology. It also uses a registered collimation design that aligns each collimator hole with a single detector pixel. This design eliminates the impact of collimator resolution that would normally affect the overall system resolution. The result is an improved contrast-to-noise ratio⁵ and spatial resolution down to 2.8 mm.⁶
https://www.gehealthcare.com/products/molecular-imaging/nuclear-medicine/nm-ct-870-czt
CdZnTe Association (CdZnTe.com)
https://www.cdznte.com/detector/ge-healthcare-nm-ct-870-czt.html
